Roopa Padavagodu Shivananda

Roopa Padavagodu Shivananda

Auto-generated profile, based on publicly available information

Roopa Padavagodu Shivananda

Obstetrics and Gynecology, Manipal Academy of Higher Education, Manipal, Karnataka, India

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 September 2022 in AJOG Global Reports
Verified
Journal Article
Open access
AVAkhila Vasudeva
Akhila Vasudeva
RSRoopa Padavagodu Shivananda
Roopa Padavagodu Shivananda
DSDisha Shree Belathur Shashidar
Disha Shree Belathur Shashidar
AMAnjali Mundkur
Anjali Mundkur
JSJyothi Samanth
Jyothi Samanth
PNPratap Kumar Narayan
Pratap Kumar Narayan
Doppler studies of uteroplacental–fetal circulation have been proven useful in diagnosing fetal growth restriction, appropriately timing delivery, and improving perinatal morbidity and mortality. There has been an extensive search for the ideal means to identify fetuses between the compensatory and acidemic phase (ie, the “preacidemic phase”), and the aortic isthmus Doppler seems to show promise. This study aimed to investigate: (1) the prevalence of abnormal aortic isthmus Dopplers in a cohort of small-for-gestational-age fetuses and their correlation with other conventional Doppler abnormalities, and (2) the predictive ability of abnormal aortic isthmus Dopplers with regard to short-term adverse neonatal outcomes. Fetuses diagnosed as small-for-gestational-age at ≥24 weeks’ gestation were included. Management was as per the standard protocol. Aortic isthmus Doppler was performed within a week of delivery with other conventional Dopplers. The adverse perinatal outcomes studied were: requirement of neonatal resuscitation at birth, Apgar score at 5 minutes <7, cord blood pH <7, presence of bronchopulmonary dysplasia, hypoxic-ischemic encephalopathy, grade III/IV intraventricular hemorrhage, necrotizing enterocolitis, sepsis, neonatal intensive care unit stay longer than 14 days, and stillbirth or neonatal death. Among 121 small-for-gestational-age fetuses, 67 showed Doppler abnormalities in ≥1 vessels. The prevalence of abnormal aortic isthmus Doppler was 14.87%. Analysis was between group 1 with 103 normal aortic isthmus and group 2 with 18 abnormal aortic isthmus fetuses; 41 cases had some form of adverse perinatal outcome, the frequency of which was comparable between the groups. Abnormal aortic isthmus Doppler had a significant correlation with low cerebroplacental ratio, absent or reversed end-diastolic flow in the umbilical artery, and high pulsatility index in the ductus venosus. The positive likelihood ratio for predicting composite adverse perinatal outcome was 10.2 for absent or reversed end-diastolic flow in the umbilical artery, 9.6 for low cerebroplacental ratio, 2.28 for absent or retrograde flow in the aortic isthmus, and 2 for abnormal ductus venosus. Predelivery abnormal aortic isthmus Dopplers performed worse than other conventional Dopplers in predicting abnormal perinatal outcomes.

2 January 2024 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Open access
AVAkhila Vasudeva
Akhila Vasudeva
HKHaritha Kodavati
Haritha Kodavati
JSJyothi Samanth
Jyothi Samanth
RSRoopa Padavagodu Shivananda
Roopa Padavagodu Shivananda
SPSanghamitra Paladugu
Sanghamitra Paladugu
PKPratap Kumar
Pratap Kumar
TVS (Transvaginal Sonography) guided Cervical strain elastography (CSE) is now available in tertiary referral centers of LMICs (Low- and Middle-Income Countries). TVS cervical length (CL) assessment is being used routinely. Still, elastography is not used in clinical settings, although enough evidence suggests good predictive value towards sPTD (spontaneous Preterm Delivery). The clinical utility of elastography has not been tested among high-risk populations of LMICs for the prediction of sPTD. To test the performance of TVS-CSE in predicting sPTD among asymptomatic women in the mid-trimester at risk of sPTD either due to clinical factors or due to a short cervix. Prospective observational study performed at a tertiary hospital in South India. Asymptomatic pregnant women between 16 and 24 weeks who had one or more clinical risk factors for sPTD or CL <2.5 cm were included. GE Voluson E-8 ultrasound machine was used. After CL measurement, elastography color coding was noted around the internal-os in the sagittal view. The strain ratio (SR) was calculated using the trace method on three ROIs (Region of Interest): Internal-os in sagittal view (IN), whole cervix in sagittal view (WN), and internal-os in axial view (AN). Reference Tissue (RT) of similar size and depth was chosen in the darkest blue region on elastography (stiffest area) outside the cervix, posterior/lateral to the cervix over the ligament insertion. Lower the SR - softer the cervix. Two trained fetal medicine consultants performed the initial 57 cases until intra/inter-observer correlation was satisfactory. Delivery before 37 weeks (after 26 weeks), in which the process of labor has begun spontaneously, or labor was induced after PPROM-was considered as sPTD. SRs were assessed to determine how well they could predict sPTD independently or combined with cervical length. Out of 221 recruited,17 were lost to follow-up after 32 weeks; 204 were delivered in our hospital. Irrespective of the route of delivery, 71 (34.8%) had sPTD. Of the remaining 133, 106 delivered at term, and 27 underwent medically indicated PTD. Apart from multiple pregnancies, no other preterm-related risk factors (including CL < 2.5 cm) showed significant association with sPTD. Red CSE pattern around internal-os was associated with a significantly higher (54.5%) incidence of sPTD. CLs were similar (3.63 ± 0.67 vs. 3.63 ± 0.80, p = .981) whereas SRs in all three ROIs were significantly lower among sPTD group versus no sPTD group (IN:0.65 ± 0.29 vs 0.79 ± 0.30 p = .001, WN:0.34 ± 0.13 vs 0.39 ± 0.15, p = .013, AN:0.37 ± 0.16 vs 0.48 ± 0.26, p = .002, respectively). Using ROC curves, while CL was not predictive (AUROC 0.49, p = .81), SRs showed moderate predictive value toward sPTD with the best AUC of 0.624 (p = .003) at IN. Prediction was slightly better for early sPTD <32 weeks (AUC 0.653 p = 0.03). The best cutoff for SR at IN was 0.72, below which there was a moderate accuracy in predicting sPTD (sensitivity 52.11%, specificity 60.9%, PPV 41.57%, NPV 70.44%, diagnostic OR 1.69 and overall accuracy of 57.84%). A weak positive correlation is seen between IN and CL (Pearson's correlation R = 0.181). Multi-variable binary logistic regression analysis suggested that SRs at IN (Adjusted OR - 0.259 CI 0.079-0.850), AN (Adjusted OR 0.182 CI 0.034-0.963), Multiple Pregnancy (Adjusted OR 3.5 CI 1.51-8.13) and previous sPTD/PPROM (Adjusted OR 2.72 CI 0.97-7.61) independently predicted sPTD. TVS CSE performed better than CL as an independent predictive tool toward sPTD, although predictive efficacy was modest at best. Since technology is now available in high-end USG machines in tertiary care centers, we propose optimal utilization of CSE in LMICs to triage at-risk populations since low SRs are strongly associated with sPTD.

27 October 2020 in International Journal of Reproduction, Contraception, Obstetrics and Gynecology
Verified
Journal Article
Open access
PDF file
RSRoopa P. Shivananda
Roopa P. Shivananda
GBGurram Bhanuteja
Gurram Bhanuteja
SRShubha Rao
Shubha Rao
NHNivedita Hegde
Nivedita Hegde
SPSangamithra Paladugu
Sangamithra Paladugu
AVAkhila Vasudeva
Akhila Vasudeva
Background: Objective of this study was to audit the cases of maternal sepsis and analyze their maternal and fetal outcomes.Methods: A retrospective analysis of cases of maternal sepsis was undertaken for one year. Cases were taken as infection with fever, tachycardia, tachypnea, low oxygen saturation, high or low white blood counts and clinical or laboratory evidence of organ dysfunction and were analyzed. Demographic profile, gestational age at the time of diagnosis, organisms & their sources of infection was noted. Maternal outcomes of abortion, preterm delivery, need for intensive care unit (ICU) / high dependency unit (HDU) stay, blood and blood products, surgical interventions for the control of infection, culture-positive rate, source of organism, antibiotic usage and maternal mortality were analyzed. Fetal outcomes of early fetal demise, preterm birth, intrauterine death, stillbirth and term birth were studied. Results: There were a total of 2327 deliveries, with 2333 live births during the study period. Twenty-two cases were diagnosed with sepsis, of which 17 survived, and five died. The incidence of maternal sepsis was 9.4/1000 live births & maternal deaths were 22.7%. Ninety percent were in the age group of 21-39 years, 68% were referred, 59% were post-delivery. Fifty nine percent of women who survived, and none of the women who died had medical co-morbidities. Respiratory tract followed by genitourinary tract were the most common source of infection, though culture was negative in 54.5% of the cases. The organisms grown were varied, with Escherichia coli (3/10) contributing to 30% of the culture positive cases. Spontaneous abortion and preterm delivery were 18% each, 36% required surgical intervention, 81% required ICU and 64.7 HDU stay. Seventy-seven had live birth.Conclusions: Maternal sepsis is an evolving preventable health burden. Early recognition requires a high index of clinical suspicion, even in the absence of risk factors. Mortality to morbidity ratio is very high in maternal sepsis. The timing of sepsis determines the fetal outcomes.

28 October 2022 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
SPSanghamitra Paladugu
Sanghamitra Paladugu
AVAkhila Vasudeva
Akhila Vasudeva
VPVidyashree G Poojari
Vidyashree G Poojari
NMNehal Meghna Machado
Nehal Meghna Machado
PRP.S. Roopa
P.S. Roopa
VKVijay Kumar
Vijay Kumar

5 June 2024 in BMJ Case Reports
Verified
Journal Article
Closed access
PDF file
AVAkhila Vasudeva
Akhila Vasudeva
RSRoopa Padavagodu Shivananda
Roopa Padavagodu Shivananda
ADArun Handigodu Dugappa
Arun Handigodu Dugappa
VBVivekananda Bhat
Vivekananda Bhat
A third gravida with osteogenesis imperfecta (OI) type 1, in her 20s, was referred from the Medical Genetics department at 12+ weeks with a prenatal diagnosis of OI type 1 in this fetus for further management. She was wheelchair-bound and keen to continue this pregnancy. She had medical termination in her two previous pregnancies for OI in the fetuses. Ultrasound at 12+ weeks revealed a short-bent femur with sparing of the long bones of the upper limb. Serial ultrasound revealed progressive affliction of the long bones with falling growth profile and polyhydramnios. She was delivered at 36 weeks by caesarean for breech in labour under regional anaesthesia. A multidisciplinary approach, patient determination, and good partner support helped in the successful management of this pregnancy. The neonate had blue sclera, dentigerous imperfecta, bowing of the femur and relatively spared upper limbs. Growth was on the third centile. The mother says she brings the girl for follow-up every 3–6 months to give injection zoledronate. The mother confirms her girl can stand with support, crawl, and speak two-syllable words. Her daughter had to undergo femur corrective osteotomy rush nailing and hip spice application for a closed fracture of the left femur.

10 October 2026 in Middle East Fertility Society Journal
Verified
Journal Article
Open access
PDF file
ASAyesha Siddiqua
Ayesha Siddiqua
AMAnjali Mundkur
Anjali Mundkur
SSSujatha Bagepalli Srinivas
Sujatha Bagepalli Srinivas
RSRoopa P S
Roopa P S
In May 2026, a global consensus of 56 academic, clinical, and patient organisations formally renamed Polycystic Ovary Syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS), following a 14-year international process and more than 14,000 survey responses (1). This narrative review examines the rationale for renaming, the consensus process, and the diagnostic, clinical, therapeutic, and implementation implications for Indian reproductive medicine. PMOS is used throughout this review to refer to the current nomenclature; PCOS is reserved for historical terms, original diagnostic criteria, and quoted nomenclature. PubMed/MEDLINE, Scopus, and Embase were searched for literature on PCOS/PMOS nomenclature, epidemiology, diagnosis, phenotyping, management, mental health, and Indian/South Asian clinical characteristics. A narrative rather than systematic review was chosen given the recency of the nomenclature change and the aim of providing a broad, contextual clinical overview; PRISMA-based study selection and meta-analysis were not performed. Contemporary Indian/South Asian literature from 2015 to 2026 was prioritised, while foundational studies were included without date restriction. The 2023 International Evidence-based Guideline and the 2026 nomenclature consensus were used as primary normative sources. Globally, PMOS affects an estimated 6 to 21% of women of reproductive age depending on diagnostic criteria and population studied (2). The nationwide Indian study by Ganie et al. reported a weighted prevalence of 19.6% by Rotterdam criteria, with phenotype C predominating at 40.8% (3). The PMOS transition may improve recognition of the disorder’s systemic metabolic and psychological dimensions, but it should not be used to justify testing or treatment beyond current evidence. We distinguish guideline-supported care from emerging or experimental approaches and discuss Indian-specific feasibility, affordability, and evidence gaps.